Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stem Cell Enriched, T Cell Depleted Haplocompatible Peripheral Blood Transplantation for Children With Myelodysplastic Disease, Leukemia, Marrow Failure Syndromes, or Severe Immunodeficiency Diseases

NCT00295971 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00295971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stem Cell Enriched, T Cell Depleted Haplocompatible Peripheral Blood Transplantation for Children With Myelodysplastic Disease, Leukemia, Marrow Failure Syndromes, or Severe Immunodeficiency Diseases
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2005
Completion date
December 31, 2011
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congenital amegakaryocytic thrombocytopenia, leukemia, myelodysplastic syndromes, severe congenital neutropenia